Reply
- PMID: 36847127
- DOI: 10.1097/LVT.0000000000000094
Reply
Comment on
-
Protective effect of low-dose aspirin against acute cellular allograft rejection after primary liver transplantation.Liver Transpl. 2023 Apr 1;29(4):E3-E4. doi: 10.1097/LVT.0000000000000093. Epub 2023 Feb 8. Liver Transpl. 2023. PMID: 36746180 No abstract available.
References
-
- Oberkofler CE, Raptis DA, Muller PC, Sousa da Silva RX, Lehmann K, Ito T, et al. Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation. Liver Transpl. 2022;28:1888–98.
-
- Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280–7.
-
- Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69:345–57.
-
- Becchetti C, Dirchwolf M, Schropp J, Magini G, Müllhaupt B, Immer F, et al. Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Aliment Pharmacol Ther. 2022;56:1194–1204.
Publication types
LinkOut - more resources
Full Text Sources
